UB Paderborn / Katalog / Suche / in CDI

Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia

Leukemia, 2014-08, Vol.28 (8), p.1636-1646

2014

Volltextzugriff (PDF)

Stromal cell-induced miRNA alteration in chronic lymphocytic leukemia: how a minute and unavoidable cell contamination impairs miRNA profiling

Leukemia, 2013-08, Vol.27 (8), p.1773-1776

2013

Volltextzugriff (PDF)

Overexpression of both catalytically active and -inactive cathepsin D by cancer cells enhances apoptosis-dependent chemo-sensitivity

Oncogene, 2006-03, Vol.25 (13), p.1967-1973

2006

Volltextzugriff (PDF)

Clinical utility of complex multi-platform profiling in metastatic cancer patients

Annals of oncology, 2018-10, Vol.29, p.viii480-viii480

2018

Volltextzugriff (PDF)

Case Report: Primary Spinal Lymphoma

Bulletin de la Société des sciences médicales du Grand-Duché de Luxembourg, 2016, Vol.1, p.91

2016

Volltextzugriff (PDF)

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

The New England journal of medicine, 2014-12, Vol.371 (23), p.2167-2177

2014

Volltextzugriff (PDF)

Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1/PD-L1 immunotherapy

Science advances, 2020-05, Vol.6 (18), p.eaax7881-eaax7881

2020

Volltextzugriff (PDF)

Lighting up the fire in cold tumors to improve cancer immunotherapy by blocking the activity of the autophagy-related protein PIK3C3/VPS34

Autophagy, 2020-11, Vol.16 (11), p.2110-2111

2020

Volltextzugriff (PDF)

A secreted FGF-binding protein can serve as the angiogenic switch in human cancer

Nature medicine, 1997-10, Vol.3 (10), p.1137-1140

1997

Volltextzugriff (PDF)

Firing up the cold tumors by targeting Vps34

Oncoimmunology, 2020-01, Vol.9 (1), p.1809936-1809936

2020

Volltextzugriff (PDF)

810P PRESERV MEL: Real-world outcomes and health-related quality of life (HRQoL) in patients receiving adjuvant nivolumab for melanoma in Belgium and Luxembourg

Annals of oncology, 2022-09, Vol.33, p.S916

2022

Volltextzugriff (PDF)

Lung cancer statistics in Luxembourg from 1981 to 2008

Bulletin de la Société des sciences médicales du Grand-Duché de Luxembourg, 2011 (2), p.43

2011

Volltextzugriff (PDF)

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

The Lancet (British edition), 2009-05, Vol.373 (9674), p.1525-1531

2009

Volltextzugriff (PDF)

Melanoma Angiogenesis and Metastasis Modulated by Ribozyme Targeting of the Secreted Growth Factor Pleiotrophin

Proceedings of the National Academy of Sciences - PNAS, 1996-12, Vol.93 (25), p.14753-14758

1996

Volltextzugriff (PDF)

Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells

Cancer research (Chicago, Ill.), 1995-02, Vol.55 (4), p.735-738

1995

Volltextzugriff (PDF)

Nanomolar range docetaxel treatment sensitizes MCF-7 cells to chemotherapy induced apoptosis, induces G2M arrest and phosphorylates bcl-2

Anticancer research, 1999-01, Vol.19 (1A), p.535

1999

Volltextzugriff (PDF)

88P Efficacy of olaparib in advanced cancers occurring in patients with germline or somatic tumor mutations in homologous recombination (HR) genes, a Belgian Precision phase II basket study

Annals of oncology, 2021-09, Vol.32, p.S394-S394

2021

Volltextzugriff (PDF)

In vivo inhibition of angiogenesis and induction of apoptosis by retinoic acid in squamous cell carcinoma

Clinical cancer research, 1997-02, Vol.3 (2), p.179-184

1997

Volltextzugriff (PDF)

LBA76_PR Expected medium and long term impact of the COVID-19 outbreak in oncology

Annals of oncology, 2020-09, Vol.31, p.S1205-S1206

2020

Volltextzugriff (PDF)

108P Real-world (RW) effectiveness and safety of adjuvant nivolumab (NIVO) in patients (pts) with melanoma in Belgium and Luxembourg: PRESERV MEL

Immuno-oncology technology, 2023-12, Vol.20, p.100580, Article 100580

2023

Volltextzugriff (PDF)

A high rate of telomeric sister chromatid exchange occurs in chronic lymphocytic leukaemia B‐cells

British journal of haematology, 2016-07, Vol.174 (1), p.57-70

2016

Volltextzugriff (PDF)

1574P - Survival prolongation by rationale innovative genomics (SPRING): An international WIN consortium phase I study exploring safety and efficacy of avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates

Annals of oncology, 2019-10, Vol.30, p.v648-v648

2019

Volltextzugriff (PDF)

Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis

Oncogene, 2002-08, Vol.21 (38), p.5951-5955

2002

Volltextzugriff (PDF)

7-year results of cell therapy in patients with severe ischemic cardiomyopathy

Bulletin de la Société des sciences médicales du Grand-Duché de Luxembourg, 2011 (2), p.35

2011

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Disruption of autophagy by the histone deacetylase inhibitor MGCD0103 and its therapeutic implication in B-cell chronic lymphocytic leukemia

Stromal cell-induced miRNA alteration in chronic lymphocytic leukemia: how a minute and unavoidable cell contamination impairs miRNA profiling

Overexpression of both catalytically active and -inactive cathepsin D by cancer cells enhances apoptosis-dependent chemo-sensitivity

Clinical utility of complex multi-platform profiling in metastatic cancer patients

Case Report: Primary Spinal Lymphoma

First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer

Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti-PD-1/PD-L1 immunotherapy

Lighting up the fire in cold tumors to improve cancer immunotherapy by blocking the activity of the autophagy-related protein PIK3C3/VPS34

A secreted FGF-binding protein can serve as the angiogenic switch in human cancer

Firing up the cold tumors by targeting Vps34

810P PRESERV MEL: Real-world outcomes and health-related quality of life (HRQoL) in patients receiving adjuvant nivolumab for melanoma in Belgium and Luxembourg

Lung cancer statistics in Luxembourg from 1981 to 2008

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

Melanoma Angiogenesis and Metastasis Modulated by Ribozyme Targeting of the Secreted Growth Factor Pleiotrophin

Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells

Nanomolar range docetaxel treatment sensitizes MCF-7 cells to chemotherapy induced apoptosis, induces G2M arrest and phosphorylates bcl-2

88P Efficacy of olaparib in advanced cancers occurring in patients with germline or somatic tumor mutations in homologous recombination (HR) genes, a Belgian Precision phase II basket study

In vivo inhibition of angiogenesis and induction of apoptosis by retinoic acid in squamous cell carcinoma

LBA76_PR Expected medium and long term impact of the COVID-19 outbreak in oncology

108P Real-world (RW) effectiveness and safety of adjuvant nivolumab (NIVO) in patients (pts) with melanoma in Belgium and Luxembourg: PRESERV MEL

A high rate of telomeric sister chromatid exchange occurs in chronic lymphocytic leukaemia B‐cells

Survival prolongation by rationale innovative genomics (SPRING): An international WIN consortium phase I study exploring safety and efficacy of avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates

1574P - Survival prolongation by rationale innovative genomics (SPRING): An international WIN consortium phase I study exploring safety and efficacy of avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates

Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis

7-year results of cell therapy in patients with severe ischemic cardiomyopathy

Suchergebnisse filtern